433 - 444 of 7403 results
1 CME CREDIT

This session will review the geographical distribution of people at risk for developing celiac disease and populations that should undergo screening for celiac disease. The faculty will describe the changing presentations of celiac disease, review the gastroenterological and extraintestinal manifestations (such as irritable bowel disease), and emphasize the importance of a gluten free diet as an integral component to successful remission. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on Feb 9, 2020, and they are subject to change as new information is published.


1 CME CREDIT

With variable presentations and a chronic relapsing-remitting course of disease, systemic lupus erythematosus (SLE) poses unique challenges to clinicians. In this session, a primary care physician and rheumatologist will collaborate to unmask the disease known as the great imitator and provide you with tools for improving your SLE diagnosis and management. Through live patient-clinician interaction, the faculty will demonstrate how to communicate with patients suffering from SLE. At the end of this session, you will be able to assess patients with symptoms of lupus, diagnose SLE per published criteria, and partner efficiently with rheumatologists to treat and monitor your patients with this complex disease.


0.75 CME CREDIT

This talk will provide an opportunity for the learner to (anonymously) test his/her knowledge in the management of people with type 2 diabetes using cases and an ARS. The cases will also be used to illustrate the pathophysiology of type 2 diabetes and provide an opportunity for developing a practical approach to treating people with type 2 diabetes, utilizing the commonest and newest medications available. The cases will also help the learners use medications safely and understand advantages and disadvantages, and common side effects of each class of medication. Finally a practical approach to the initiation and intensification of basal insulin will be covered.


0.75 CME CREDIT

More than half of all mental health treatment takes place in primary care, a major burden (though also an opportunity) for providers who are expected to do so many things at once. How can psychiatry help given their limited availability across the country? Enter the Collaborative Care Model, with multiple randomized trials showing feasibility and improved outcomes from adding two main ingredients in primary care clinics: an in-house Behavioral Health Consultant who serves as liaison, data-gatherer/recorder and manager of a registry of patients who receive “treat to target” follow-up; and a remote consulting psychiatrist in regular communication with the BHC and the primary care team. This presentation will briefly describe the 5 principles which drive this Collaborative Care Model and will also focus on implementation: what steps need to be taken to incorporate such a program in a primary care practice? And how does setting and geography play a role? General guidelines from experience implementing this model in 12 different clinics will help your planning (from pre-contemplation to preparation to action!)


1 CME CREDIT

Tremendous strides have been made in the management of cerebrovascular disorders. This presentation will provide the most recent updates in the diagnosis and management of strokes and transient ischemic attacks (TIAs). Contemporary clinical trials have changed the treatment of ischemic strokes and TIAs. This session will explain how to identify the mechanism for stroke and TIA and select prevention strategies accordingly. In addition to discussing individualized management, the faculty will touch on several ongoing trials that aim to clarify alternative mechanisms for stroke and pilot new therapeutic approaches. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7th 2020 and they are subject to change as new information is published.


0.75 CME CREDIT

Overactive bladder (OAB) is a common problem affecting patients of all ages. Although often described as a quality of life issue, OAB also impacts overall health and well-being. This talk will discuss the incidence and etiology, evaluation (signs or symptoms to look out for which may indicate a concerning etiology of symptoms), and step-wise management of OAB. Behavioral, medical, and procedural management options will be presented, including botulinum toxin injection, sacral neuromodulation, and percutaneous nerve stimulation.


0.5 CME CREDIT

Polypharmacy, defined as the use of multiple drugs or more than are medically necessary, is a growing concern for older adults. With older adults living longer and experiencing multiple chronic comorbidities, medication regimens are becoming increasingly complex and lengthy. It is not unusual to see patients taking 10 or more medications. Unfortunately, polypharmacy has been associated with an increased risk of adverse drug events (ADEs), drug-interactions, medication non-adherence, reduced functional capacity and multiple geriatric syndromes. This lecture will present real-world cases of polypharmacy and review the concepts of de-prescribing, what medications are no longer considered helpful to older adults, and how to safely reduce polypharmacy in real-world settings among patients.


1.25 CME CREDITS

There have been many advances in the medical management of dermatologic disease. Office Dermatology will cover the diagnosis and management of common skin disorders and provide an update on therapeutics.


0.75 CME CREDIT

An engaging review of the significance of and treatment options for coronary artery disease in women will build on participant knowledge. The speaker will also identify differences in clinical presentation by gender and symptoms and age and offer insight on appropriate diagnostic approaches.


0.75 CME CREDIT

In this talk, the speaker will discuss goals of treatment as it relates to microvascular complication risk reduction and reasons for using insulin in specific populations, focusing on type 2 diabetes. Additionally, learners will review currently available short- and long-acting insulins on the U.S. market and associated risks and benefits of use. Finally, the speaker will expand on the practical use of insulin (i.e., when to start, how to titrate, etc.).


1 CME CREDIT

Faculty will review the prior data regarding antiplatelet and anticoagulant therapy. He will also present highlights from the recent late breaking clinical trial presentations from the European Society of Cardiology.


0.75 CME CREDIT

This talk will focus on three major areas of interest. 1. Cerebrovascular disease and stroke prevention: newer information regarding intensive medical therapy and new interventional approaches for primary prevention. 2. Abdominal aortic aneurysm: methods of diagnosis, indications for surgery, and newer methods of intervention. 3. Peripheral vascular disease: methods of diagnosis, medical management, and indications for invasive intervention.